Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

E-ISSN： 1875-5968|4|5|449-455

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.5, 2004-09, pp. : 449-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 7, 2011-09 ,pp. : 638-642

Bentham Science Publishers

Access to resources Recommend Favorite

Mini-Review: Bmx Kinase Inhibitors for Cancer Therapy

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-09 ,pp. : 228-238

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?

By Kirkali Ziya Tüüzel Emre

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 871-888

Future Medicine

Access to resources Recommend Favorite

Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy

By Zhang Jiao Chen Yan-Hua Lu Qun

Future Oncology, Vol. 6, Iss. 4, 2010-04 ,pp. : 587-603

Future Medicine

Access to resources Recommend Favorite

Kinase Inhibitors in Prostate Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1089-1104

Bentham Science Publishers

Access to resources Recommend Favorite